Cargando…
Fluticasone furoate induced iatrogenic Cushing syndrome in a pediatric patient receiving anti-retroviral therapy
SUMMARY: We present a case of iatrogenic Cushing’s syndrome, induced by treatment with fluticasone furoate (1–2 dd, 27.5 µg in each nostril) in a pediatric patient treated for congenital HIV. The pediatric patient described in this case report is a young girl of African descent, treated for congenit...
Autores principales: | van den Berg, S A A, van ‘t Veer, N E, Emmen, J M A, van Beek, R H T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404706/ https://www.ncbi.nlm.nih.gov/pubmed/28458904 http://dx.doi.org/10.1530/EDM-16-0158 |
Ejemplares similares
-
Adrenal insufficiency in a woman secondary to standard-dose inhaled fluticasone propionate therapy
por: Hay, Casey M, et al.
Publicado: (2014) -
Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
por: Sai, Katta, et al.
Publicado: (2019) -
Reversible alterations in cardiac morphology and functions in a patient with Cushing's syndrome
por: Iwasaki, Hiroaki
Publicado: (2014) -
Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone
por: Dow, Adrienne, et al.
Publicado: (2013) -
Vandetanib induces a marked anti-tumor effect and amelioration of ectopic
Cushing’s syndrome in a medullary thyroid carcinoma patient
por: Bseiso, Hashem, et al.
Publicado: (2016)